
FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions
The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable limitations. FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions Previously available under emergency use authorization for individuals aged 12 and up, the shot is now fully approved only for adults 65 and older, or for…